Laura Clague Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Laura Clague.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Laura Clague. Laura Clague is Director in LRAD Corp ($LRAD) and Director in FLUIDIGM CORP ($FLDM) and Chief Financial Officer in Retrophin, Inc. ($RTRX).
Latest Insider Trading Transactions of Laura Clague
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FLDM, LRAD, RTRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 19.46 | 2,000 | 38,920 | 28,223 | 30.2 K to 28.2 K (-6.62 %) |
| May 13 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 19.14 | 2,000 | 38,280 | 30,223 | 32.2 K to 30.2 K (-6.21 %) |
| Mar 18 2021 | LRAD | Genasys Inc. | Clague Laura | Director | Grant | A | 0.00 | 27,883 | 0 | 168,027 | 140.1 K to 168 K (+19.90 %) |
| Mar 12 2021 | LRAD | Genasys Inc. | Clague Laura | Director | Option Exercise | M | 2.02 | 20,000 | 40,400 | 0 | |
| Mar 12 2021 | LRAD | Genasys Inc. | Clague Laura | Director | Sell | S | 7.42 | 5,456 | 40,465 | 170,144 | 175.6 K to 170.1 K (-3.11 %) |
| Mar 12 2021 | LRAD | Genasys Inc. | Clague Laura | Director | Buy | M | 2.02 | 20,000 | 40,400 | 175,600 | 155.6 K to 175.6 K (+12.85 %) |
| Feb 23 2021 | FLDM | FLUIDIGM CORP | Clague Laura | Director | Grant | A | 0.00 | 9,803 | 0 | 37,159 | 27.4 K to 37.2 K (+35.83 %) |
| Feb 09 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 31.58 | 2,250 | 71,055 | 32,223 | 34.5 K to 32.2 K (-6.53 %) |
| Feb 09 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 31.41 | 2,250 | 70,673 | 34,473 | 36.7 K to 34.5 K (-6.13 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 4,500 | 0 | 36,723 | 32.2 K to 36.7 K (+13.97 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 4,500 | 0 | 36,723 | 32.2 K to 36.7 K (+13.97 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 28.91 | 1,125 | 32,524 | 32,223 | 33.3 K to 32.2 K (-3.37 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 28.91 | 2,500 | 72,275 | 33,348 | 35.8 K to 33.3 K (-6.97 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 30.75 | 1,125 | 34,594 | 35,848 | 37 K to 35.8 K (-3.04 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 30.75 | 2,500 | 76,875 | 36,973 | 39.5 K to 37 K (-6.33 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 5,000 | 0 | 39,473 | 34.5 K to 39.5 K (+14.50 %) |
| Jan 25 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Option Exercise | A | 26.88 | 57,500 | 1,545,600 | 57,500 | |
| Jan 25 2021 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 34,473 | 19.5 K to 34.5 K (+77.03 %) |
| Nov 17 2020 | RTRX | Travere Therapeuti ... | Clague Laura | Chief Financial Off ... | Sell | S | 23.98 | 7,500 | 179,813 | 19,473 | 27 K to 19.5 K (-27.81 %) |
| Nov 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 23.61 | 7,500 | 177,071 | 26,973 | 34.5 K to 27 K (-21.76 %) |
| Nov 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 34,473 | 19.5 K to 34.5 K (+77.03 %) |
| Sep 23 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 18.48 | 1,500 | 27,720 | 19,473 | 21 K to 19.5 K (-7.15 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 18.59 | 1,500 | 27,885 | 20,973 | 22.5 K to 21 K (-6.67 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 3,000 | 0 | 22,473 | 19.5 K to 22.5 K (+15.41 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 18.59 | 1,500 | 27,885 | 20,973 | 22.5 K to 21 K (-6.67 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 3,000 | 0 | 22,473 | 19.5 K to 22.5 K (+15.41 %) |
| Jun 25 2020 | FLDM | FLUIDIGM CORP | Clague Laura | Director | Option Exercise | A | 3.74 | 20,993 | 78,514 | 20,993 | |
| Jun 25 2020 | FLDM | FLUIDIGM CORP | Clague Laura | Director | Grant | A | 0.00 | 13,369 | 0 | 27,356 | 14 K to 27.4 K (+95.58 %) |
| May 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 16.98 | 527 | 8,951 | 19,473 | 20 K to 19.5 K (-2.63 %) |
| May 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 17.16 | 1,250 | 21,450 | 20,000 | 21.3 K to 20 K (-5.88 %) |
| May 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 14.95 | 1,250 | 18,688 | 21,250 | 22.5 K to 21.3 K (-5.56 %) |
| May 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 16.98 | 527 | 8,951 | 19,473 | 20 K to 19.5 K (-2.63 %) |
| May 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 17.16 | 1,250 | 21,450 | 20,000 | 21.3 K to 20 K (-5.88 %) |
| May 13 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 14.95 | 1,250 | 18,688 | 21,250 | 22.5 K to 21.3 K (-5.56 %) |
| Mar 12 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 15.02 | 4,000 | 60,080 | 22,500 | 26.5 K to 22.5 K (-15.09 %) |
| Mar 12 2020 | LRAD | Genasys Inc. | Clague Laura | Director | Option Exercise | M | 0.00 | 30,000 | 0 | 0 | |
| Mar 12 2020 | LRAD | Genasys Inc. | Clague Laura | Director | Buy | M | 0.00 | 30,000 | 0 | 155,600 | 125.6 K to 155.6 K (+23.89 %) |
| Mar 12 2020 | LRAD | Genasys Inc. | Clague Laura | Director | Grant | A | 0.00 | 30,000 | 0 | 125,600 | 95.6 K to 125.6 K (+31.38 %) |
| Mar 09 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 4,000 | 0 | 26,500 | 22.5 K to 26.5 K (+17.78 %) |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 15.46 | 55,000 | 850,300 | 55,000 | |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 22,500 | 13.5 K to 22.5 K (+66.67 %) |
| Jun 05 2019 | FLDM | FLUIDIGM CORP | Clague Laura | Director | Option Exercise | A | 13.41 | 6,796 | 91,134 | 6,796 | |
| Jun 05 2019 | FLDM | FLUIDIGM CORP | Clague Laura | Director | Option Exercise | A | 13.41 | 6,796 | 91,134 | 6,796 | |
| Jun 05 2019 | FLDM | FLUIDIGM CORP | Clague Laura | Director | Grant | A | 0.00 | 3,987 | 0 | 13,987 | 10 K to 14 K (+39.87 %) |
| Jun 05 2019 | FLDM | FLUIDIGM CORP | Clague Laura | Director | Grant | A | 0.00 | 3,987 | 0 | 13,987 | 10 K to 14 K (+39.87 %) |
| May 16 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 18.71 | 1,250 | 23,388 | 13,500 | 14.8 K to 13.5 K (-8.47 %) |
| May 16 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 17.78 | 1,250 | 22,225 | 14,750 | 16 K to 14.8 K (-7.81 %) |
| May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
| May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
| Mar 20 2019 | LRAD | LRAD Corp | Clague Laura | Director | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Mar 20 2019 | LRAD | LRAD Corp | Clague Laura | Director | Buy | M | 0.00 | 25,000 | 0 | 95,600 | 70.6 K to 95.6 K (+35.41 %) |
| Mar 13 2019 | LRAD | LRAD Corp | Clague Laura | Director | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Feb 13 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 21.50 | 1,016 | 21,844 | 10,000 | 11 K to 10 K (-9.22 %) |
| Feb 13 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 21.38 | 1,017 | 21,743 | 11,016 | 12 K to 11 K (-8.45 %) |
| Dec 21 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 22.34 | 900 | 20,109 | 12,033 | 12.9 K to 12 K (-6.96 %) |
| Dec 21 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 21.67 | 2,850 | 61,751 | 12,933 | 15.8 K to 12.9 K (-18.06 %) |
| Dec 21 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 22.08 | 3,750 | 82,805 | 15,783 | 19.5 K to 15.8 K (-19.20 %) |
| Dec 20 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 7,500 | 0 | 19,533 | 12 K to 19.5 K (+62.33 %) |
| Nov 16 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 24.73 | 791 | 19,562 | 12,033 | 12.8 K to 12 K (-6.17 %) |
| Nov 16 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 24.20 | 2,959 | 71,605 | 12,824 | 15.8 K to 12.8 K (-18.75 %) |
| Nov 16 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 24.54 | 400 | 9,816 | 15,783 | 16.2 K to 15.8 K (-2.47 %) |
| Nov 16 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 23.63 | 3,350 | 79,154 | 16,183 | 19.5 K to 16.2 K (-17.15 %) |
| Nov 01 2018 | FLDM | FLUIDIGM CORP | Clague Laura | Director | Option Exercise | A | 7.42 | 15,000 | 111,300 | 15,000 | |
| Nov 01 2018 | FLDM | FLUIDIGM CORP | Clague Laura | Director | Option Exercise | A | 7.42 | 15,000 | 111,300 | 15,000 | |
| Nov 01 2018 | FLDM | FLUIDIGM CORP | Clague Laura | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Nov 01 2018 | FLDM | FLUIDIGM CORP | Clague Laura | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| May 14 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
| May 14 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 25.25 | 48,000 | 1,212,000 | 48,000 | |
| May 14 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 12,033 | 2 K to 12 K (+491.88 %) |
| Mar 21 2018 | LRAD | LRAD Corp | Clague Laura | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 95,600 | |
| Mar 16 2018 | LRAD | LRAD Corp | Clague Laura | Director | Option Exercise | M | 0.00 | 25,000 | 0 | 70,600 | |
| Mar 16 2018 | LRAD | LRAD Corp | Clague Laura | Director | Buy | M | 0.00 | 25,000 | 0 | 70,600 | 45.6 K to 70.6 K (+54.82 %) |
| Feb 12 2018 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 2,033 | 0 | 2,033 | 0 to 2 K |
| May 19 2017 | LRAD | LRAD Corp | Clague Laura | Director | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| May 19 2017 | LRAD | LRAD Corp | Clague Laura | Director | Buy | M | 0.00 | 25,000 | 0 | 47,600 | 22.6 K to 47.6 K (+110.62 %) |
| May 18 2017 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 17.44 | 60,000 | 1,046,400 | 60,000 | |
| Mar 16 2017 | LRAD | LRAD Corp | Clague Laura | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Mar 16 2017 | LRAD | LRAD Corp | Clague Laura | Director | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| May 23 2016 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 16.23 | 60,000 | 973,800 | 60,000 | |
| Jul 06 2015 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 32.49 | 60,000 | 1,949,400 | 60,000 | |
| Mar 19 2015 | LRAD | LRAD Corp | Clague Laura | Director | Option Exercise | A | 2.16 | 20,000 | 43,200 | 20,000 | |
| Feb 02 2007 | LRAD | LRAD Corp | Clague Laura | Director | Option Exercise | A | 4.42 | 50,000 | 221,000 | 50,000 |
Page: 1